ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/20/2023
Back to search
Official data from USPTO
WORLDWIDE CLINICAL TRIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000077070676Class
35, 37, 41, 42
Filing
77070676
Registration
3521264
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
12/20/2023
Trademark type
Combined
Nice classes
35, 37, 41, 42
Filing date
12/22/2006
Registration date
10/21/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2018
Last transaction
10/05/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2008
First use in commerce
06/30/2008
Drawing code
3
Owner type
03
Owner location
BEVERLY HILLS, CA
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the image of a globe bisected with the image of a caduceus above the words "WORLDWIDE CLINICAL TRIALS".
Holders and representatives
Holders
WORLDWIDE CLINICAL TRIALS, INC.
WCT HOLDINGS, LLC
WORLDWIDE CLINICAL TRIALS, LLC
Maple Leaf Ventures, LLC
Representatives
Brian R. McGinley DENTONS US LLP
Technical classification
Nice Classes
Class 35Class 37Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management assistance and consultation for clinical trials of investigational drugsarranging for sites to perform clinical trialsarranging for the importpackagingshippinglabelingdistribution of drugs and other investigational supplies to and from the clinical trial sitesarranging for the central collection of laboratory specimens from clinical trial sitesmaking any and all filings required by the food and drug administration for investigational new drugspreparing statistical reports resulting from clinical trials
Class 37
Real estate site selectioninspecting potential sites for hosting clinical trials
Class 41
Training clinical trial site personnel concerning drug protocol requirements and the use of tests and rating systems for such protocol; training clinical trial site personnel in the use of medical and research equipment required by drug protocols
Class 42
Technical writing of clinical report forms for others which are required by clinical trial drug protocols; technical writing of clinical trial reports for others; database development services to process data collected from clinical trials
Publications
History of USPTO decisions and trademark events.
56 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/01/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/05/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/05/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/05/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/05/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
09/28/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/28/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/21/2017
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
02/20/2015
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
02/10/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/07/2015
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/06/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/25/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/25/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/25/2014
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
02/10/2014
E815
TEAS SECTION 8 & 15 RECEIVED
02/10/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/26/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/14/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/20/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/01/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/15/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/08/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/01/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/18/2011
CORV
REVIEW OF CORRESPONDENCE COMPLETE
12/28/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/28/2010
PAPER RECEIVED
10/14/2010
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/19/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/12/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/09/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/15/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/15/2008
IUAF
USE AMENDMENT FILED
08/04/2008
EISU
TEAS STATEMENT OF USE RECEIVED
08/04/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/04/2008
PUBO
PUBLISHED FOR OPPOSITION
12/11/2007
NPUB
NOTICE OF PUBLICATION
11/21/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/08/2007
ALIE
ASSIGNED TO LIE
11/08/2007
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/10/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/26/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/29/2007
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/02/2007
CNRT
NON-FINAL ACTION MAILED
04/25/2007
CNRT
NON-FINAL ACTION WRITTEN
04/25/2007
DOCK
ASSIGNED TO EXAMINER
04/17/2007
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
12/29/2006
NWAP
NEW APPLICATION ENTERED
12/28/2006
Continuous trademark protection
Get notified about every new filing that threatens WORLDWIDE CLINICAL TRIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.